
    
      The main objectives of this study are to:

        -  Evaluate the safety of ALX-101 Gel 5% when applied topically twice daily in subjects
           with moderate atopic dermatitis compared with a matching ALX-101 Gel Vehicle

        -  Evaluate the efficacy of ALX-101 Gel 5% when applied topically twice daily in subjects
           with moderate atopic dermatitis compared with a matching ALX-101 Gel Vehicle
    
  